The macrocyclic peptide rhesus theta defensin 1 activates interferon and antiviral pathways in human monocytes
Journal of Leukocyte Biology · 2025
DOI: 10.1093/jleuko/qiaf150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Prasad Tongaonkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States. Hauptthemen laut MEDLINE: Monocytes, Defensins, Signal Transduction, Interferons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NCI NIH HHS.
Abstract (Originalsprache)
Rhesus theta defensin (RTD)-1, a cyclic antimicrobial peptide, regulates gene expression and immune signaling pathways in cell culture and animal models of immune-mediated diseases. In lipopolysaccharide-stimulated cells, RTD-1 inhibition of proinflammatory cytokine secretion and gene expression is mediated through inhibition of the NF-κB and MAP kinase signaling pathways. To gain insights into RTD-1 regulation of naïve cells, we performed RNA sequencing (RNA-seq) to determine the effect of the peptide on global gene expression in human monocytes and THP-1 monocytes. In both cell types, analysis of differentially expressed genes revealed stimulation of interferon and antiviral gene expression pathways. RTD-1 induced Y701 phosphorylation of STAT1 and activated the ISRE reporter in a JAK-dependent manner. Stimulation of the ISRE reporter by RTD-1 was interferon-α/β receptor dependent but was independent of its NF-κB inhibitory activity in lipopolysaccharide-stimulated cells. RTD-1 inhibited infection of vesicular stomatitis virus pseudotyped with G glycoprotein or SARS-CoV-2 spike protein in THP-1 and Vero E6 cells, respectively. RTD-1 also inhibited infection of Calu-3 2B4 cells by SARS-CoV-2 virus, demonstrating antiviral activity of RTD-1 in diverse cell types. These results demonstrate that RTD-1 stimulates interferon and antiviral pathways, potentially priming cells for resistance to viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States.
- Biosafety Level 3 Facility in the Hastings Foundation and the Wright Foundation Laboratories, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States.
- Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States.
- USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, United States.
ORCID-Profile: Prasad Tongaonkar
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- NCI NIH HHS
- COVID-19 Keck Research Fund
- University of Southern California Norris Comprehensive Cancer Center
- Hastings Foundation
- National Cancer Institute
Zitieren
APA
Tongaonkar, P., Trinh, K. K., Henley, J. E., Sell, P. J., Thakker, V., Ouellette, A. J., & Selsted, M. E. (2025). The macrocyclic peptide rhesus theta defensin 1 activates interferon and antiviral pathways in human monocytes. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf150
Vancouver
Tongaonkar P, Trinh KK, Henley JE, Sell PJ, Thakker V, Ouellette AJ, et al. The macrocyclic peptide rhesus theta defensin 1 activates interferon and antiviral pathways in human monocytes. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf150
BibTeX
@article{Tongaonkar2025,
author = {Tongaonkar, Prasad and Trinh, Katie K and Henley, Jill E and Sell, Philip J and Thakker, Vyoma and Ouellette, André J and Selsted, Michael E},
title = {The macrocyclic peptide rhesus theta defensin 1 activates interferon and antiviral pathways in human monocytes},
journal = {Journal of Leukocyte Biology},
year = {2025},
doi = {10.1093/jleuko/qiaf150}
}
EUVIMED